CN1112834A - Method for preparing oral liquid for treating hepatitis B and its product - Google Patents
Method for preparing oral liquid for treating hepatitis B and its product Download PDFInfo
- Publication number
- CN1112834A CN1112834A CN 94109284 CN94109284A CN1112834A CN 1112834 A CN1112834 A CN 1112834A CN 94109284 CN94109284 CN 94109284 CN 94109284 A CN94109284 A CN 94109284A CN 1112834 A CN1112834 A CN 1112834A
- Authority
- CN
- China
- Prior art keywords
- radix
- fructus
- herba
- hepatitis
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000002672 hepatitis B Diseases 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 8
- 239000007788 liquid Substances 0.000 title claims description 24
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 5
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 5
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 5
- 210000000582 semen Anatomy 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 16
- 238000007796 conventional method Methods 0.000 claims description 12
- 239000000796 flavoring agent Substances 0.000 claims description 8
- 235000019634 flavors Nutrition 0.000 claims description 8
- 230000002787 reinforcement Effects 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 4
- 238000013467 fragmentation Methods 0.000 claims description 4
- 238000006062 fragmentation reaction Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000012856 packing Methods 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 235000014375 Curcuma Nutrition 0.000 claims description 3
- 241000202807 Glycyrrhiza Species 0.000 claims description 3
- 241001529553 Scoparia <angiosperm> Species 0.000 claims description 3
- 241000207929 Scutellaria Species 0.000 claims description 3
- 244000164439 Curcuma angustifolia Species 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 241001529821 Agastache Species 0.000 abstract 1
- 239000010231 banlangen Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 4
- 241000407170 Curcuma Species 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000007449 liver function test Methods 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 240000002514 Cymbidium ensifolium Species 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 235000018958 Gardenia augusta Nutrition 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A preparation method of a medicine for treating hepatitis B and its product are provided. The product contains bupleuri radix, rhizoma Cyperi, radix Curcumae, radix Angelicae sinensis, radix Paeoniae alba, Atractylodis rhizoma, Poria, rhizoma paridis, Bulbus Allii Macrostemi, fructus Lycii, Glycyrrhrizae radix, herba Menthae, fructus Gardeniae, herba Artemisiae Scopariae, radix Isatidis, Scutellariae radix, radix Sophorae Flavescentis, radix rehmanniae, fructus Aurantii, fructus crataegi, Raphani semen, herba Schisandrae chinensis, Notoginseng radix, Saviae Miltiorrhizae radix, shanmeiqi, oleum Menthae Dementholatum, rhizoma Acori Graminei, herba Agastaches, etc. The product obtained by the method can radically cure hepatitis B, and has the advantages of short treatment period, quick response, safety, reliability and no side effect.
Description
The present invention relates to a kind of manufacture method of controlling the hepatitis B medicine and products thereof.
There are the various hepatitis B medicines of controlling to sell at present on the market, certain therapeutic effect is arranged, but all there is not late result, can not effect a radical cure hepatitis B, so that the hepatitis B disease is still wildness and stretches uncontrollable, many hepatitis B patients lose normal viability because of obstinate, even are developed to the serious disastrous effect of " sclerosis " " canceration ".Though the hepatitis B patient who has can obtain " false ", the misfortune that be unable to escape recurrence eventually, cancerates, this just gives the human human body and brings great infringement mentally.
The object of the present invention is to provide and a kind ofly can fundamentally cure hepatitis B, treatment cycle is short, and instant effect is safe and reliable, Bao oral liquid of the hepatitis B that has no side effect and preparation method thereof.
The technical solution of the present invention i.e. manufacture method of the Bao oral liquid of this hepatitis B is as follows:
A, with 2~4% CAIHU, 3~5% radix curcumaes, 4~6% Radix Angelicae Sinensis, 4~6% Radix Paeoniae Albas, 4~6% Rhizoma Atractylodis Macrocephalaes, 4~6% Poria, the 4th~6% full buildings, 4~6% Bulbus Allii Macrostemonis, 5~7% Fructus Lyciis, 3~5% Radix Glycyrrhizaes, 1~3% Herba Menthae, 4~7% Fructus Gardeniae, 4~6% Herba Artemisiae Scopariaes, 4~6% Radix Isatidiss, 4~6% Radix Scutellariaes, 5~7% Radix Sophorae Flavescentiss, 5~7% Radix Rehmanniae, 2~4% Fructus Aurantiis, 4~6% Fructus Crataegis, 2~4% Semen Raphanis (the above-mentioned unit of weight that is) mix homogeneously, make main body according to a conventional method and decoct juice;
B, the Fructus Schisandrae Chinensis fourth after the fragmentation is immersed in concentration according to a conventional method is in 95% the ethanol, obtains saturated broken flavor fourth liquid;
It is that obtaining concentration is 45~55%(weight/volume in 95% the ethanol that c, the Radix Notoginseng with 50~60%, 25~35% Dan Xiang, 1~3% SHANGMEIQI, 0.5~1.5% Oleum menthae, 8~12% Rhizoma Acori Graminei (mentioned component is unit of weight) mix homogeneously are immersed in concentration) the reinforcement solution that looses;
D, Herba Pogostemonis decocted according to a conventional method obtain Herba Pogostemonis and decoct juice;
E, with 92~95%(volume) main body decoct juice, 1~2%(volume) broken flavor fourth liquid, 2~4%(volume) reinforcement loose solution and 2~4%(volume) Herba Pogostemonis decoct the juice mix homogeneously, after filtration, sterilization, packing, check obtain finished product.
The Bao oral liquid of hepatitis B of the present invention can be made concentrated oral liquid as required, or is mixed with the dilution oral liquid with distilled water, and the oral liquid of 500 milliliters of not diluted can divide and take in 3~7 days.Patient can take 30~90 days continuously according to the weight of the state of an illness; General patient can cure a course of treatment, and more serious 2~3 courses of treatment of need treatment, 3 months is a course of treatment.
The Bao oral liquid of hepatitis B of the present invention can fundamentally be cured hepatitis B, and clinical effective rate is 100%, and cure rate and state of an illness negative conversion rate are more than 90%, no longer recurrence after healing, lifetime immunity and cross immunity.The treatment cycle of this oral liquid is short, and instant effect is safe and reliable, has no side effect.
Below in conjunction with embodiment and clinical example the present invention is described in more detail.
Embodiment 1:
The Bao oral liquid of this hepatitis B is made by following method:
A, with 3% CAIHU, 4.5% Rhizoma Cyperi, 3.8% radix curcumae, 5.2% Radix Angelicae Sinensis, 5% Radix Paeoniae Alba, 4% Rhizoma Atractylodis Macrocephalae, 6% Poria, the 4.5%th full building, 5.4% Bulbus Allii Macrostemonis, 6% Fructus Lycii, 4% Radix Glycyrrhizae, 3% Herba Menthae, 5% Fructus Gardeniae, 5.5% Herba Artemisiae Scopariae, 5.5% Cymbidium ensifolium (L.) Sw. root, 4% Radix Scutellariae, 7% Radix Sophorae Flavescentis, 5% Radix Rehmanniae, 3% Fructus Aurantii, 6% Fructus Crataegi, 4% Semen Raphani (the above-mentioned unit of weight that is) mix homogeneously, make main body with conventional method and decoct juice;
B, the Fructus Schisandrae Chinensis fourth after the fragmentation is immersed in concentration according to a conventional method is in 95% the ethanol, obtains saturated broken flavor fourth liquid;
C, the Radix Notoginseng with 55%, 2% Dan Xiang, 2% SHANGMEIQI, 0.8% Oleum menthae, 10.2% Rhizoma Acori Graminei (mentioned component is unit of weight) mix homogeneously are immersed in concentration and are in 95% the ethanol, and obtaining concentration is the 50%(weight/volume) reinforcement solution;
D, Herba Pogostemonis decocted according to a conventional method obtain Herba Pogostemonis and decoct juice;
E, with the 95%(volume) main body decoct juice, 1%(volume) broken flavor fourth liquid, 2%(volume) reinforcement loose solution and 2%(volume) Herba Pogostemonis decoct the juice mix homogeneously, after filtration, sterilization, packing, check obtain finished product.
Embodiment 2:
The Bao oral liquid of this hepatitis B is made by following method:
A, with 20 gram CAIHU, 25 gram Rhizoma Cyperis, 23 gram radix curcumaes, 22 gram Radix Angelicae Sinensis, the 20 gram Radix Paeoniae Albas, the 30 gram Rhizoma Atractylodis Macrocephalaes, 25 gram Poria, 25 gram Jin Lou, 22.5 gram Bulbus Allii Macrostemonis, 32.5% Fructus Lyciis, 25 gram Radix Glycyrrhizaes, 10 gram Herba Menthaes, 30 Keshan Cape jasmines, 22.5 gram Herba Artemisiae Scopariaes, 22.5 gram Radix Isatidiss, 30 gram Radix Scutellariaes, 25 gram Radix Sophorae Flavescentiss, the 30 gram Radix Rehmanniae, 20 gram Fructus Aurantiis, 25 Keshan short, bristly hair or beards, 15 gram Semen Raphani mix homogeneously, decoct with conventional method and to obtain main body and decoct juice;
B, the Fructus Schisandrae Chinensis fourth after the fragmentation is immersed in concentration according to a conventional method is in 95% the ethanol, obtains saturated broken flavor fourth liquid;
C, with 58 gram Radix Notoginsengs, 28 Ke Dan townshiies, 3 gram SHANGMEIQIs, 1 gram Oleum menthae, 10 gram Rhizoma Acori Graminei mix homogeneously, be immersed in concentration and be in 95% the ethanol, obtain 200 milliliters the reinforcement solution that looses;
D, 100 gram Herba Pogostemoniss are decocted according to a conventional method obtain Herba Pogostemonis and decoct juice;
E, 92 milliliters of main bodys are decocted juice, 2 milliliters of broken flavor fourth liquid, 4 milliliters strengthen loosing solution and 4 milliliters of Herba Pogostemoniss decoct the juice mix homogeneously, after filtration, sterilization, packing, check obtain the Bao oral liquid of 100 milliliters of hepatitis B.
Clinical example 1:
Patient: the technique center Wang Li of Shiyan City, Hubei Province No. 2 Automobile Factory, do liver function test and find that GPT increases, surface antigen belongs to positive, be diagnosed as hepatitis B, do not see obvious improvement, after take the Bao oral liquid of trimestral hepatitis B of the present invention through hospitalize, the every index of liver function test is normal, appetite increases, and has rosy cheeks, and all malaise symptoms are thoroughly eliminated.
Clinical example 2:
Patient: the Wu Qiuping of production scheduling place of Shiyan City, Hubei Province No. 2 Automobile Factory, suffer from the serious symptom hepatitis B did not heal in hospital in four months, no appetite, malaise is after take the Bao oral liquid of trimestral hepatitis B of the present invention, liver function check and ultrasound diagnosis index are normal, special examination two double full feminine genders that belong to, physical recovery has been married as before, given birth to child, always operate as normal and life.
Claims (1)
1, manufacture method of a kind of hepatitis B oral liquid and products thereof is characterized in that:
A, with 2~4% CAIHU, 3~5% radix curcumaes, 4~6% Radix Angelicae Sinensis, 4~6% Radix Paeoniae Albas, 4~6% Rhizoma Atractylodis Macrocephalaes, 4~6% Poria, the 4th~6% full buildings, 4~6% Bulbus Allii Macrostemonis, 5~7% Fructus Lyciis, 3~5% Radix Glycyrrhizaes, 1~3% Herba Menthae, 4~7% Fructus Gardeniae, 4~6% Herba Artemisiae Scopariaes, 4~6% Radix Isatidiss, 4~6% Radix Scutellariaes, 5~7% Radix Sophorae Flavescentiss, 5~7% Radix Rehmanniae, 2~4% Fructus Aurantiis, 4~6% Fructus Crataegis, 2~4% Semen Raphanis (the above-mentioned unit of weight that is) mix homogeneously, make main body according to a conventional method and decoct juice
B, the Fructus Schisandrae Chinensis fourth after the fragmentation is immersed in concentration according to a conventional method is in 95% the ethanol, obtains saturated broken flavor fourth liquid,
It is in 95% the ethanol that c, the Radix Notoginseng with 50~60%, 25~35% Dan Xiang, 1~3% SHANGMEIQI, 0.5~1.5% Oleum menthae, 8~12% Rhizoma Acori Graminei (mentioned component is unit of weight) mix homogeneously are immersed in concentration, obtaining concentration is the diffusing solution of reinforcement of 45~55% (weight/volume)
D, Herba Pogostemonis decocted according to a conventional method obtain Herba Pogostemonis and decoct juice,
The loose Herba Pogostemonis of solution and 2~4% (volume) of e, the reinforcement that the main body of 92~95% (volumes) is decocted broken flavor fourth liquid, 2~4% (volumes) of juice, 1~2% (volume) decocts the juice mix homogeneously, after filtration, sterilization, packing, check obtain finished product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 94109284 CN1112834A (en) | 1994-08-29 | 1994-08-29 | Method for preparing oral liquid for treating hepatitis B and its product |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 94109284 CN1112834A (en) | 1994-08-29 | 1994-08-29 | Method for preparing oral liquid for treating hepatitis B and its product |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1112834A true CN1112834A (en) | 1995-12-06 |
Family
ID=5033848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 94109284 Pending CN1112834A (en) | 1994-08-29 | 1994-08-29 | Method for preparing oral liquid for treating hepatitis B and its product |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1112834A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1054540C (en) * | 1998-01-12 | 2000-07-19 | 李铁敏 | Chinese medicinal preparation for resisting hepatitis B virus and its preparation method |
CN1061554C (en) * | 1998-11-19 | 2001-02-07 | 潘建新 | Chinese patent drug for curing hepatitis B |
CN1061869C (en) * | 1996-09-10 | 2001-02-14 | 吴荫福 | Recovering powder for hepatitis B |
CN1098089C (en) * | 1998-04-28 | 2003-01-08 | 天津市新迪亚医药新技术发展有限公司 | Medicine for treating hepatitis and liver fibrosis, and method for preparing same |
CN100382824C (en) * | 2006-04-24 | 2008-04-23 | 辽宁本溪三药有限公司 | Chinese traditional medicine for treating chronic hepatitis, and preparation method |
US8080264B2 (en) * | 2004-11-24 | 2011-12-20 | Himalaya Global Holdings Ltd. | Natural composition for curing hepatitis-B, methods for making the same and pharmaceutical formulations thereof |
CN107362329A (en) * | 2017-07-20 | 2017-11-21 | 闫鹏生 | A kind of Chinese medicine treated hepatitis B great three positive and turned out cloudy |
-
1994
- 1994-08-29 CN CN 94109284 patent/CN1112834A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1061869C (en) * | 1996-09-10 | 2001-02-14 | 吴荫福 | Recovering powder for hepatitis B |
CN1054540C (en) * | 1998-01-12 | 2000-07-19 | 李铁敏 | Chinese medicinal preparation for resisting hepatitis B virus and its preparation method |
CN1098089C (en) * | 1998-04-28 | 2003-01-08 | 天津市新迪亚医药新技术发展有限公司 | Medicine for treating hepatitis and liver fibrosis, and method for preparing same |
CN1061554C (en) * | 1998-11-19 | 2001-02-07 | 潘建新 | Chinese patent drug for curing hepatitis B |
US8080264B2 (en) * | 2004-11-24 | 2011-12-20 | Himalaya Global Holdings Ltd. | Natural composition for curing hepatitis-B, methods for making the same and pharmaceutical formulations thereof |
CN100382824C (en) * | 2006-04-24 | 2008-04-23 | 辽宁本溪三药有限公司 | Chinese traditional medicine for treating chronic hepatitis, and preparation method |
CN107362329A (en) * | 2017-07-20 | 2017-11-21 | 闫鹏生 | A kind of Chinese medicine treated hepatitis B great three positive and turned out cloudy |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1305844A (en) | Medicine for treating congestive heart failure | |
CN1709422A (en) | Novel use of Chinese patent medicine formulation with bone-promoting formation for preventing and treating osteoporosis | |
CN101028481A (en) | Medicinal liquor for treating hyperosteogeny and lumbar intervertebral disc protrusion | |
CN1193775C (en) | Rheumatoid disease treating capsule | |
CN1891279A (en) | Capsule for treating cardio-cerebrovasular disease | |
CN1112834A (en) | Method for preparing oral liquid for treating hepatitis B and its product | |
CN101637559B (en) | Instant oral liquid for kidney stone | |
CN1994453B (en) | Orally administered Chinese medicine for treating dysmenorrheal caused by qi stagnation and blood stasis | |
CN1111522A (en) | Compound islets Langerhans regenerated capsule | |
CN101167932A (en) | Traditional Chinese medicine for treating chronic hepatitis B | |
CN1657067A (en) | Chinese medicine for treating psoriasis | |
CN1120943A (en) | Nose opening capsule and its preparation method | |
CN101953924A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN1365819A (en) | Medicine for treating apoplexy | |
CN1331996A (en) | Hepatitis B treaitng pill | |
CN1269231A (en) | Sanbiwan bolus | |
CN1087821A (en) | A kind of medicament and preparation method of removing acne | |
CN1127344C (en) | Oral pill for curing diabetes and its complication | |
CN101953925A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN1117384A (en) | Traditional Chinese medicinal prescription (capsule series) for treating cardiovascular disease or cerebrovascular disease and method for mfg. same | |
CN104971327A (en) | Traditional Chinese medicinal preparation for treating wind-heat type common cold | |
CN1293908C (en) | Cancer preventing and curing Chinese medicine of two snakes and Ganoderma Lucidum seu Japonicum | |
CN1255149C (en) | Combination of medication | |
CN1322558A (en) | Liver cancer resisting medicine | |
CN1772095A (en) | Chinese medicine for treating menorrhagia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |